Rekvina Laboratories Limited (BOM:526075)
India · Delayed Price · Currency is INR 49.90
-1.01 (-1.98%)
At close: Sep 25, 2026
Rekvina Laboratories Market Cap
Rekvina Laboratories has a market cap or net worth of 554.68 million as of September 25, 2026. Its market cap has increased by 1,944.81% in one year.
Market Cap
554.68M
Enterprise Value
569.25M
Revenue
19.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.90
ChartMarket Cap Chart
Since July 26, 2013, Rekvina Laboratories's market cap has increased from 443.60M to 554.68M, an increase of 25.04%. That is a compound annual growth rate of 1.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 554.68M | 1,944.81% |
| Dec 13, 2021 | 27.13M | 4.65% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Source Natural Foods and Herbal Supplements | 701.30M |
| Onyx Biotec | 652.76M |
| Shelter Pharma | 627.17M |
| Phaarmasia | 611.35M |
| Cian Healthcare | 565.50M |
| Biofil Chemicals and Pharmaceuticals | 532.97M |
| ANG Lifesciences India | 525.86M |
| Mangalam Drugs & Organics | 504.92M |